These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 11762428)

  • 1. Antidepressant discontinuation in the context of cognitive behavioral treatment for panic disorder.
    Schmidt NB; Wollaway-Bickel K; Trakowski JH; Santiago HT; Vasey M
    Behav Res Ther; 2002 Jan; 40(1):67-73. PubMed ID: 11762428
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Discontinuation of benzodiazepine treatment: efficacy of cognitive-behavioral therapy for patients with panic disorder.
    Otto MW; Pollack MH; Sachs GS; Reiter SR; Meltzer-Brody S; Rosenbaum JF
    Am J Psychiatry; 1993 Oct; 150(10):1485-90. PubMed ID: 8379551
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cognitive-behavior therapy for discontinuation of SSRI treatment of panic disorder: a case series.
    Whittal ML; Otto MW; Hong JJ
    Behav Res Ther; 2001 Aug; 39(8):939-45. PubMed ID: 11480834
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Does cognitive behavior therapy assist slow-taper alprazolam discontinuation in panic disorder?
    Spiegel DA; Bruce TJ; Gregg SF; Nuzzarello A
    Am J Psychiatry; 1994 Jun; 151(6):876-81. PubMed ID: 8184997
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy of CBT for benzodiazepine discontinuation in patients with panic disorder: Further evaluation.
    Otto MW; McHugh RK; Simon NM; Farach FJ; Worthington JJ; Pollack MH
    Behav Res Ther; 2010 Aug; 48(8):720-7. PubMed ID: 20546699
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cognitive-behavioral therapy, imipramine, or their combination for panic disorder: A randomized controlled trial.
    Barlow DH; Gorman JM; Shear MK; Woods SW
    JAMA; 2000 May; 283(19):2529-36. PubMed ID: 10815116
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Severity of panic disorder, adverse events in childhood, dissociation, self-stigma and comorbid personality disorders Part 2: Therapeutic effectiveness of a combined cognitive behavioural therapy and pharmacotherapy in treatment-resistant inpatients.
    Kolek A; Prasko J; Ociskova M; Holubova M; Vanek J; Grambal A; Slepecky M
    Neuro Endocrinol Lett; 2019 Dec; 40(6):271-283. PubMed ID: 32200586
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cognitive-behavioral therapy helps prevent relapse and recurrence of panic disorder following alprazolam discontinuation: a long-term follow-up of the Peoria and Dartmouth studies.
    Bruce TJ; Spiegel DA; Hegel MT
    J Consult Clin Psychol; 1999 Feb; 67(1):151-6. PubMed ID: 10028220
    [TBL] [Abstract][Full Text] [Related]  

  • 9. International Study of Expert Judgement on Therapeutic Use of Benzodiazepines and Other Psychotherapeutic Medications: V. Treatment strategies in panic disorder, 1992-1997.
    Uhlenhuth EH; Balter MB; Ban TA; Yang K
    J Clin Psychopharmacol; 1998 Dec; 18(6 Suppl 2):27S-31S. PubMed ID: 9872710
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Medication discontinuation in panic disorder.
    Ballenger JC
    J Clin Psychiatry; 1992 Mar; 53 Suppl():26-31. PubMed ID: 1548252
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Randomised placebo-controlled trial of moclobemide, cognitive-behavioural therapy and their combination in panic disorder with agoraphobia.
    Loerch B; Graf-Morgenstern M; Hautzinger M; Schlegel S; Hain C; Sandmann J; Benkert O
    Br J Psychiatry; 1999 Mar; 174():205-12. PubMed ID: 10448444
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cognitive-behavioral group therapy for panic disorder in the general clinical setting: a naturalistic study with 1-year follow-up.
    Martinsen EW; Olsen T; Tønset E; Nyland KE; Aarre TF
    J Clin Psychiatry; 1998 Aug; 59(8):437-42; quiz 443. PubMed ID: 9721829
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Review of the long-term effectiveness of cognitive behavioral therapy compared to medications in panic disorder.
    Nadiga DN; Hensley PL; Uhlenhuth EH
    Depress Anxiety; 2003; 17(2):58-64. PubMed ID: 12621593
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recognition and treatment of panic disorder.
    Lydiard RB
    J Clin Psychiatry; 2007 Nov; 68(11):e26. PubMed ID: 18052552
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cognitive-behavioral therapy and the treatment of panic disorder: efficacy and strategies.
    Otto MW; Deveney C
    J Clin Psychiatry; 2005; 66 Suppl 4():28-32. PubMed ID: 15842185
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combined antidepressants and CBT for panic disorder with agoraphobia.
    Coupland NJ
    J Psychiatry Neurosci; 2008 Mar; 33(2):176. PubMed ID: 18330461
    [No Abstract]   [Full Text] [Related]  

  • 17. Benzodiazepine discontinuation difficulties in panic disorder: conceptual model and outcome for cognitive-behavior therapy.
    Otto MW; Hong JJ; Safren SA
    Curr Pharm Des; 2002; 8(1):75-80. PubMed ID: 11812251
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cognitive behaviour therapy for withdrawal from antidepressant medication: a single case series.
    Cromarty P; Jonsson J; Moorhead S; Freeston MH
    Behav Cogn Psychother; 2011 Jan; 39(1):77-97. PubMed ID: 20849682
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of cognitive-behavioral treatment on quality of life in panic disorder patients.
    Telch MJ; Schmidt NB; Jaimez TL; Jacquin KM; Harrington PJ
    J Consult Clin Psychol; 1995 Oct; 63(5):823-30. PubMed ID: 7593876
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Predictors of alprazolam discontinuation with and without cognitive behavior therapy in panic disorder.
    Bruce TJ; Spiegel DA; Gregg SF; Nuzzarello A
    Am J Psychiatry; 1995 Aug; 152(8):1156-60. PubMed ID: 7625463
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.